0000000000272451

AUTHOR

Tatiana Eremkina

showing 3 related works from this author

Omega-(Hetarilamino-N-(1,3-tiazol-2-il)alkānamīdu sintēze un īpašības

2012

Darbā veikta 1,2,3,4-tetrahidro(izo)hinolīna, 5-aminohinolīna un 2-amino(benz)tiazola N-alkilēšanas reakcija ar hloraizvietotiem heterociklu amīdiem dažādos reakcijas apstākļos, ka arī tālāka amīda saites reducēšana iegūtajos savienojumos. Izpētīta 4-hlor-N-(1,3-tiazol-2-il)butānamīda ciklizācijas reakcija un atrasti apstākļi kas ļauj vienkārši un ar augstiem iznākumiem iegūt 1-(1,3-(benz)tiazol-2-il)pirrolidīn-2-onus. Darba rezultātā iegūti jauni, potenciāli bioloģiski aktīvi ω-(hetarilamino)-N-(1,3-tiazol-2-il)alkānamīdi un to analogi, kas satur divu heterociklu atlikumus, dažādās kombinācijās, savienotus ar dažāda tipa saiti. Sintezēto savienojumu struktūras pierādītas ar dažādām fizikāl…

Ķīmija
researchProduct

Synthesis, physicochemical characterization, cytotoxicity, antimicrobial, anti-inflammatory and psychotropic activity of new N-[1,3-(benzo)thiazol-2-…

2012

Abstract A series of new N-[(benzo)thiazol-2-yl]-2/3-[3,4-dihydroisoquinolin-2(1H)-yl]ethan/propanamide derivatives was synthesized and characterized by 1H, 13C NMR and IR spectroscopy and mass-spectrometry. A single crystal X-ray study of N-(1,3-benzothiazol-2-yl)-2-[3,4-dihydroisoquinolin-2(1H)-yl]ethanamide is reported to determine its conformational feature. The investigated compounds were found to be active in psychotropic in vivo, anti-inflammatory in vivo and cytotoxicity in vitro screening. They possess marked sedative action, reveal high anti-inflammatory activity, have selective cytotoxic effects and NO-induction ability concerning tumour cell lines. Some of the compounds synthesi…

Models MolecularAntifungal AgentsStereochemistrymedicine.drug_classInfrared spectroscopyAntineoplastic AgentsMicrobial Sensitivity TestsCarrageenanCrystallography X-RayAnti-inflammatorychemistry.chemical_compoundMiceStructure-Activity RelationshipSeizuresCell Line TumorDrug DiscoverymedicineAnimalsEdemaHumansBenzothiazolesThiazoleCytotoxicityHypoxiaPsychomotor AgitationCell ProliferationPharmacologyPsychotropic DrugsBacteriaDose-Response Relationship DrugMolecular StructureTetrahydroisoquinolineChemistry PhysicalOrganic ChemistryAnti-Inflammatory Agents Non-SteroidalFungiGeneral MedicineCarbon-13 NMRAntimicrobialIsoquinolinesPropanamideAnti-Bacterial AgentschemistryNIH 3T3 CellsDrug Screening Assays AntitumorAnesthesia InhalationEuropean journal of medicinal chemistry
researchProduct

CCDC 907303: Experimental Crystal Structure Determination

2014

Related Article: Alla Zablotskaya, Izolda Segal, Athina Geronikaki, Tatiana Eremkina, Sergey Belyakov, Marina Petrova, Irina Shestakova, Liga Zvejniece, Vizma Nikolajeva|2013|Eur.J.Med.Chem.|70|846|doi:10.1016/j.ejmech.2013.10.008

Space GroupCrystallographyCrystal SystemN-(13-Benzothiazol-2-yl)-2-(34-dihydroisoquinolin-2(1H)-yl)acetamideCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct